Hepatitis C Facts - Idenix Announces Thirteen Data Presentations at the 2006 European Association for the Study of the Liver
Idenix Announces Thirteen Data Presentations at the 2006 European Association for the Study of the Liver
[Press Release] PR Newswire via Yahoo! Finance - Mar 17 5:33 AM
Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases, announced today that thirteen abstracts have been accepted for presentation at the 41st annual meeting of the European Association for the Study of the Liver , to be held in Vienna, Austria from April Save to My Web
Transition Therapeutics Acquires Exclusive License to GLP-1 for Type I Diabetes Patent Portfolio
[Press Release] CNW Group via Yahoo! Finance - Mar 14 3:30 AM
Transition Therapeutics Inc. , announced the signing of an exclusive license agreement to a patent portfolio for the use of Glucagon-Like Peptide-1 analogues in the treatment of Type I diabetes.Save to My Web
Nofa bares rules for player transfer
Sun Star - Mar 15 9:57 PM
FOLLOWING its adoption and implementation of "club membership" in the association, the Negros Occidental Football Association (Nofa) headed by Fourth District Representative Charlie 0. Cojuangco (Negros Occidental) has started to implement rules covering the transfer of players particularly at the start of the forthcoming summer tournament season when Nofa is about to stage the Nofa-Red Ribbon Save to My Web
NOFA age-group football camp forthcoming
Sun Star - Mar 07 9:20 PM
ASIDE from staging the 2006 Negros Occidental Football Association (NOFA) Red Ribbon-Under-15 and Under-17 inter-Clubs Provincial Football Championships starting April 17, the association likewise plans to stage competitions in the Under-14, 11-12, 9-10 and 6-8 age-group categories to complete its calendar of tournaments in the various divisions among member clubs in the province.Save to My Web
